GE Healthcare's (GEHC) MIM Software recently announced the receipt of FDA clearance for its Monte Carlo Dosimetry, marking a significant advancement in theranostics. This innovative solution is designed to improve the precision of radiation dose calculations for personalized treatment plans in nuclear medicine, particularly for patients receiving radiopharmaceutical therapies. The technology is pivotal in tailoring treatments specifically to the individual needs of patients, thereby maximizing therapeutic b ...